US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist

2.290
+0.220+10.63%

Close Nov 22 16:00 ET

2.270
-0.020-0.87%

Post 20:01 ET

260.82MMarket Cap-1396P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.197M	--
--	2024/Q4	-- / 1.567M	--
--	2024/Q3	3.074M / 1.445M	--
--	2024/Q2	6.772M / 1.548M	--
May 9, 2024	2024/Q1	1.925M / 1.260M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.197M--

--2024/Q4-- / 1.567M--

--2024/Q33.074M / 1.445M--

--2024/Q26.772M / 1.548M--

May 9, 20242024/Q11.925M / 1.260M--

Unlock Free Earnings Estimates

Open Account

Fate Therapeutics Earnings Reports

Fate Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 05:11

Fate Therapeutics | 8-K: Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Nov 13 05:10

Fate Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 04:14

Fate Therapeutics | 8-K: Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

Aug 14 04:08

Analyst Rating

Updated: Nov 22, 2024

Buy

Buy
25.00%
Hold
75.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall